Laser eye treatment

A laser treatment developed by Prof John Marshall from King’s College London could help reverse the effects of age-related macular degeneration.

A laser treatment developed by Prof John Marshall from the Rayne Institute at King’s College London could help reverse the effects of AMD (age-related macular degeneration), the leading cause of blindness in over 60s in the western world.

Improvements to sight were reported in early proof-of-concept trials.

AMD affects more than 200,000 people in the UK and attacks the central vision.

It develops when a membrane at the back of the eye becomes clogged with natural waste materials produced by the light-sensitive cells, which clouds vision.

In youthful eyes, enzymes clear away the debris, but as the ageing process sets in this system can fail.

The painless ‘short pulse’ laser works by boosting the release of the enzymes to clean away the waste without damaging the cells that enable humans to see.

Early tests proved promising in around 50 people with diabetic eye disease – chosen as a model because the problems develop faster than in AMD.

Prof Marshall now plans more studies in patients already suffering from AMD in one eye, with the aim of saving the sight in their better eye for as long as possible.

He said once people have advanced AMD in one eye, studies show the condition usually develops in the second eye in 18 to 36 months.

‘If you can delay the onset by three, four, six, seven or 10 years, it’s proof of the principle,’ he said.

‘What this laser is doing is trying to treat the underlying ageing process, as it were: reset the clock so that you don’t have the manifestations of visual loss.’

He said the aim was to prevent damage and preserve their sight for the rest of their lives.

Prof Marshall said he hoped the treatment would be available within two to five years and one day people in their 40s with a family history of AMD could choose to have the treatment as a way of preventing the onset of the condition.

Tom Pey, director of external affairs for Guide Dogs for the Blind, which funded the research, said: ‘This is potentially a huge breakthrough for millions of people across the world.’